Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$656M |
| 2 |
S&P Global
SPGI
|
+$588M |
| 3 |
Tesla
TSLA
|
+$386M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$561M |
| 2 |
United Therapeutics
UTHR
|
+$499M |
| 3 |
Flutter Entertainment
FLUT
|
+$445M |
| 4 |
WRK
WestRock Company
WRK
|
+$308M |
| 5 |
Visa
V
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18% |
| 2 | Consumer Discretionary | 6.63% |
| 3 | Financials | 5.84% |
| 4 | Healthcare | 4.98% |
| 5 | Industrials | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Anterix
ATEX
$1.72B
| $330K | ﹤0.01% |
8,758
+5,943
| +211% | +$229K |
|
3877
Innodata
INOD
$1.81B
| $329K | ﹤0.01% |
19,645
+13,628
| +226% | +$230K |
|
3878
Navitas Semiconductor
NVTS
$2.54B
| $329K | ﹤0.01% |
134,354
+53,765
| +67% | +$175K |
|
3879
Bioventus
BVS
$889M
| $328K | ﹤0.01% |
27,445
+18,923
| +222% | +$164K |
|
|
SHYF
3880
DELISTED
The Shyft Group
SHYF
| $328K | ﹤0.01% |
26,116
+17,314
| +197% | +$223K |
|
3881
JPMorgan Diversified Return International Equity ETF
JPIN
$364M
| $326K | ﹤0.01% |
5,430
+620
| +13% | +$35.8K |
|
3882
Vanda Pharmaceuticals
VNDA
$304M
| $326K | ﹤0.01% |
69,504
+54,434
| +361% | +$292K |
|
3883
Invesco Golden Dragon China ETF
PGJ
$96.3M
| $326K | ﹤0.01% |
11,558
+1,855
| +19% | +$41.6K |
|
3884
LoveSac
LOVE
$242M
| $326K | ﹤0.01% |
11,362
+7,861
| +225% | +$196K |
|
|
SNBR
3885
DELISTED
Sleep Number
SNBR
| $325K | ﹤0.01% |
17,729
+12,596
| +245% | +$165K |
|
3886
Takeda Pharmaceutical
TAK
$56.7B
| $325K | ﹤0.01% |
22,837
-4,676
| -17% | -$66.3K |
|
3887
Grindr
GRND
$3.06B
| $324K | ﹤0.01% |
27,191
+20,077
| +282% | +$238K |
|
|
DFSD
3888
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.09B
| $324K | ﹤0.01% |
+6,794
| New | +$322K |
|
3889
Immersion
IMMR
$243M
| $324K | ﹤0.01% |
36,295
+27,180
| +298% | +$277K |
|
3890
OrthoPediatrics
KIDS
$513M
| $324K | ﹤0.01% |
11,942
+8,248
| +223% | +$250K |
|
3891
RCM Technologies
RCMT
$202M
| $324K | ﹤0.01% |
15,957
+11,508
| +259% | +$222K |
|
3892
Kodak
KODK
$809M
| $323K | ﹤0.01% |
68,530
+30,478
| +80% | +$159K |
|
3893
Sagimet Biosciences
SGMT
$435M
| $323K | ﹤0.01% |
116,730
-19,014
| -14% | -$58.6K |
|
3894
Barclays
BCS
$87.8B
| $323K | ﹤0.01% |
26,611
-5,162
| -16% | -$60.4K |
|
3895
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$140M
| $323K | ﹤0.01% |
6,267
+4,046
| +182% | +$201K |
|
3896
CorMedix
CRMD
$564M
| $322K | ﹤0.01% |
39,905
+27,680
| +226% | +$150K |
|
3897
Schwab US REIT ETF
SCHH
$11.7B
| $322K | ﹤0.01% |
13,891
-9,353
| -40% | -$205K |
|
3898
iShares Morningstar Mid-Cap ETF
IMCB
$1.65B
| $322K | ﹤0.01% |
4,233
+778
| +23% | +$56.5K |
|
3899
Genie Energy
GNE
$370M
| $321K | ﹤0.01% |
19,733
+9,285
| +89% | +$152K |
|
3900
Limoneira
LMNR
$244M
| $319K | ﹤0.01% |
12,053
+8,338
| +224% | +$191K |
|
Similar funds
Citigroup's Q3 2024 Portfolio in Review
As of Q3 2024, Citigroup held 5,895 positions worth $173B, up 11% from $156B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup deployed $7.75B of net new capital in Q3 2024, opening 351 new positions and adding to 3,206 existing holdings. Its largest new stake was Smurfit Westrock: 1,562,261 shares worth $77.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $561M trimmed.
- Citigroup's largest Q3 2024 buy was Smurfit Westrock: 1,562,261 shares worth $77.2M.
- Citigroup added most to Caterpillar in Q3 2024, an estimated $656M increase.
- Citigroup's biggest Q3 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $561M.
- Citigroup fully exited WestRock Company in Q3 2024, selling an estimated $308M.
- Citigroup's ten largest holdings make up 21% of its $173B portfolio in Q3 2024.
- Citigroup opened 351 new positions and closed 235 in Q3 2024.
- Citigroup's portfolio value rose 11% quarter-over-quarter to $173B.
Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.